Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-04-08 Sale |
2022-04-11 8:02 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
1,025 | $27.05 | $27,726 | 5,411 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:45 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
359 | $23.8 | $8,544 | 3,001 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:45 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
472 | $23.8 | $11,234 | 5,743 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
553 | $23.8 | $13,161 | 6,161 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:42 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
782 | $23.8 | $18,612 | 21,273 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:41 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
1,501 | $23.8 | $35,724 | 63,195 (Direct) |
View |
2022-02-23 Sale |
2022-02-25 5:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
3,928 | $23.8 | $93,486 | 98,570 (Direct) |
View |
2022-01-06 Sale |
2022-01-10 6:25 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
538 | $23.05 | $12,401 | 4,361 (Direct) |
View |
2022-01-06 Sale |
2022-01-10 6:24 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
574 | $23.05 | $13,231 | 16,467 (Direct) |
View |
2022-01-06 Sale |
2022-01-10 6:23 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
1,937 | $23.05 | $44,648 | 55,908 (Direct) |
View |
2022-01-06 Sale |
2022-01-10 6:22 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
3,718 | $23.05 | $85,700 | 77,772 (Direct) |
View |
2021-11-22 Sale |
2021-11-23 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
2,803 | $19.01 | $53,285 | 47,762 (Direct) |
View |
2021-10-18 Sale |
2021-10-19 5:31 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
1,338 | $17.41 | $23,295 | 41,034 (Direct) |
View |
2021-10-18 Sale |
2021-10-19 5:30 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
2,963 | $17.41 | $51,586 | 58,844 (Direct) |
View |
2021-04-30 Sale |
2021-04-30 6:55 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO |
1,032 | $20.33 | $20,981 | 17,044 (Direct) |
View |
2021-04-30 Sale |
2021-04-30 6:54 pm |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
1,054 | $20.33 | $21,428 | 17,381 (Direct) |
View |
2021-04-30 Sale |
2021-04-30 6:53 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
4,230 | $20.33 | $85,996 | 55,666 (Direct) |
View |
2021-04-30 Sale |
2021-04-30 6:52 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
7,850 | $20.33 | $159,591 | 80,562 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-04-07 Exercise |
2022-04-11 8:02 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
2,977 | $0 | 5,411 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 7:00 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
21,832 | $0 | 21,832 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:56 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
89,062 | $0 | 89,062 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:49 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, Chief Financial Officer |
93,515 | $0 | 93,515 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:47 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary |
181,072 | $0 | 181,072 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:42 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
305,007 | $0 | 305,007 (Direct) |
View |
2022-04-05 Option Award |
2022-04-07 6:39 pm |
N/A 2032-04-05 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
584,595 | $0 | 584,595 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:45 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
840 | $0 | 3,001 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:45 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,106 | $0 | 5,743 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
1,352 | $0 | 6,161 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:42 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
2,213 | $0 | 21,273 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:41 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
4,919 | $0 | 63,195 (Direct) |
View |
2022-02-23 Exercise |
2022-02-25 5:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
10,945 | $0 | 98,570 (Direct) |
View |
2022-01-06 Exercise |
2022-01-10 6:25 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
1,286 | $0 | 4,361 (Direct) |
View |
2022-01-06 Exercise |
2022-01-10 6:24 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
1,633 | $0 | 16,467 (Direct) |
View |
2022-01-06 Exercise |
2022-01-10 6:23 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
5,444 | $0 | 55,908 (Direct) |
View |
2022-01-06 Exercise |
2022-01-10 6:22 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
9,527 | $0 | 77,772 (Direct) |
View |
Ownership |
2021-12-20 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. Chief Financial Officer |
0 | $0 | 152,688 (Direct) |
View |
2021-11-19 Exercise |
2021-11-23 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
6,250 | $0 | 47,762 (Direct) |
View |
2021-11-17 Option Award |
2021-11-19 6:36 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
31,720 | $0 | 31,720 (Direct) |
View |
2021-11-17 Option Award |
2021-11-19 6:35 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
79,302 | $0 | 79,302 (Direct) |
View |
Ownership |
2021-11-05 4:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial |
0 | $0 | 93,208 (Direct) |
View |
2021-10-15 Exercise |
2021-10-19 5:31 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
2,969 | $0 | 41,034 (Direct) |
View |
2021-10-15 Exercise |
2021-10-19 5:30 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
5,938 | $0 | 58,844 (Direct) |
View |
2021-09-29 Exercise |
2021-10-01 5:33 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
1,918 | $0 | 3,837 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:42 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director |
18,028 | $0 | 18,028 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:41 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
18,028 | $0 | 18,028 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:41 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
18,028 | $0 | 18,028 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:39 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
18,028 | $0 | 18,028 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:38 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
18,028 | $0 | 18,028 (Direct) |
View |
2021-06-22 Option Award |
2021-06-24 4:22 pm |
N/A 2031-06-21 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
36,056 | $0 | 38,681,903 (Indirect) |
View |
2021-04-29 Exercise |
2021-04-30 6:55 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO |
3,245 | $0 | 17,044 (Direct) |
View |
2021-04-29 Exercise |
2021-04-30 6:54 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
3,005 | $0 | 17,381 (Direct) |
View |
2021-04-29 Exercise |
2021-04-30 6:53 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
9,615 | $0 | 55,666 (Direct) |
View |
2021-04-29 Exercise |
2021-04-30 6:52 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
15,625 | $0 | 80,562 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 9:52 pm |
N/A 2031-02-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Stankovic Srdjan R. President |
92,140 | $0 | 92,140 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 9:48 pm |
N/A 2031-02-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James Principal Accounting Officer |
9,547 | $0 | 9,547 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 9:47 pm |
N/A 2031-02-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO |
46,070 | $0 | 46,070 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 9:46 pm |
N/A 2031-02-23 |
ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel |
41,463 | $0 | 41,463 (Direct) |
View |
2021-02-23 Option Award |
2021-02-25 9:45 pm |
N/A 2031-02-23 |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
205,012 | $0 | 205,012 (Direct) |
View |